Citius Pharmaceuticals Inc
CTXR
Common Stock
$0.75
Sector: Health Care
Industry: Pharmaceuticals
Sub-Industry: Pharmaceuticals
|
|
|
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.23 | -$0.45 | -$0.77 | -$1.17 | -$1.89 |
Sales/Revenue | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Sales Growth | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$23.05 M | -$17.55 M | -$15.56 M | -$12.54 M | -$10.39 M |
Net Income Growth | -31.38% | -12.76% | -24.13% | -20.72% | 0.00% |
Net Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -$23.37 M | -$17.56 M | -$15.60 M | -$13.43 M | -$9.98 M |
Cost of Goods Sold (incl D&A) | $0.16 M | $0.15 M | $0.00 M | $0.00 M | $0.00 M |
Cost of Goods Sold (excl D&A) | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Cost of Goods Growth | 8.21% | 16962.04% | -49.06% | -33.40% | 0.00% |
Research & Development | $12.24 M | $8.81 M | $8.60 M | $6.56 M | $2.94 M |
Other SG&A Expenses | $0.00 M | $8.75 M | $7.00 M | $6.87 M | $7.05 M |
Interest Expense | $0.01 M | $0.02 M | $0.02 M | $0.02 M | $0.85 M |
Income Tax | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.05 | -$0.06 | -$0.03 | -$0.05 |
Sales/Revenue | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Sales Growth | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$7.56 M | -$9.23 M | -$4.96 M | -$5.82 M |
Net Income Growth | 18.04% | -85.95% | 14.82% | -41.28% |
Net Margin | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -$7.55 M | -$9.22 M | -$5.16 M | -$5.94 M |
Cost of Goods Sold (incl D&A) | $0.04 M | $0.04 M | $0.04 M | $0.04 M |
Cost of Goods Sold (excl D&A) | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Cost of Goods Growth | 1.98% | 1.97% | 2.60% | 2.69% |
Research & Development | $3.45 M | $5.46 M | $2.29 M | $2.20 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $0.00 M | $3.74 M |
Interest Expense | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Income Tax | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $0.83 M | $0.99 M | $0.00 M | $0.00 M | $0.00 M |
Cash and Short-Term Investment | $70.07 M | $13.86 M | $7.89 M | $9.18 M | $3.20 M |
Cash and Short-Term Investment Growth | 405.59% | 75.58% | -14.05% | 186.63% | 0.00% |
Long Term Debt | $0.68 M | $1.02 M | $0.00 M | $0.00 M | $0.00 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $142.43 M | $43.77 M | $36.75 M | $31.05 M | $24.42 M |
Total Assets Growth | 225.38% | 19.12% | 18.34% | 27.17% | 0.00% |
Inventories | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Finished Goods | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Short Term Debt | $0.18 M | $0.33 M | $0.17 M | $0.17 M | $0.17 M |
Total Liabilities | $9.65 M | $10.10 M | $9.59 M | $3.18 M | $2.47 M |
2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $0.74 M | $0.79 M | $0.83 M | $0.87 M | $0.91 M |
Cash and Short-Term Investment | $55.76 M | $65.42 M | $70.07 M | $115.66 M | $103.70 M |
Cash and Short-Term Investment Growth | -14.77% | -6.64% | -39.42% | 11.54% | 0.00% |
Long Term Debt | $0.58 M | $0.63 M | $0.68 M | $0.72 M | $0.93 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $127.79 M | $137.52 M | $142.43 M | $146.59 M | $134.67 M |
Total Assets Growth | -7.08% | -3.45% | -2.84% | 8.86% | 0.00% |
Inventories | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Finished Goods | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Short Term Debt | $0.19 M | $0.18 M | $0.18 M | $0.34 M | $0.34 M |
Total Liabilities | $9.59 M | $12.96 M | $9.65 M | $9.31 M | $8.90 M |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|---|---|
2024-08-16 | 100 | $2.70 K |
Quarter | Amount | Yield |
---|
|
|